Computational assessment of improved cell-kill by gadolinium-supplemented boron neutron capture therapy

Physics in Medicine and Biology

Volumn 48, Issue 23, 2003, Pages 3943-3959

  Culbertson, Christopher N ^a   Jevremovic, Tatjana ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; CELLS; COMPUTATIONAL METHODS; DOSIMETRY; GADOLINIUM; NEUTRONS; TUMORS;

THERAPEUTIC RATIO;

BIOMEDICAL ENGINEERING;

BORON 10; GADOLINIUM;

APOPTOSIS; ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG TRANSPORT; MATHEMATICAL COMPUTING; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; TUMOR VOLUME;

APOPTOSIS; BORON; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; DIAGNOSIS, COMPUTER-ASSISTED; GADOLINIUM; HUMANS; ISOTOPES; MODELS, BIOLOGICAL; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0347382647     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/48/23/010     Document Type: Article

References (36)

1. Allen B, McGregor B and Martin R 1989 Neutron capture therapy with gadolinium-157 Strahlenther. Onkol. 165 156-7
2. Briesmeister J 1997 MCNP - a general Monte Carlo N-particle transport code, version 4B LA-12625-M Los Alamos National Laboratory
3. Busse P M et al 2002 A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of NCT for intracranial disease Research and Development in Neutron Capture Therapy: Proc. 10th Int. Congress on Neutron Capture Therapy pp 1123-8
4. Capala J et al 2002 Clinical BNCT studies in Sweden Research and Development in Neutron Capture Therapy: Proc. 10th Int. Congress on Neutron Capture Therapy pp 1101-6
5. Ceberg C, Persson A, Brun A, Huiskamp R, Salford L and Persson B 1995 A stochastic model for subcellular dosimetry in boron neutron capture therapy Phys. Med. Biol. 40 1819-30
6. Coderre, J A, Makar M S, Micca P L, Nawrocky M M, Liu H B, Joel D D, Stakin D N and Amols H I 1993 Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo Int. J. Radiat. Oncol. Biol. Phys. 27 1121-9
7. Gabel D, Foster S and Fairchild R 1987 The Monte Carlo simulation of the biological effects of the 10B(n,a) 7Li reaction in cells and tissue and its implications for boron neutron capture therapy Radiat. Res. 111 14-25
8. 157Gd Nucl. Phys. A 304 327-428
9. Groshev L, Demidov A, Pelekhov V and Sokolovskii L 1968 Compendium of thermal-neutron-capture gamma-ray measurements: II. Z = 47 to Z = 67, Ag to Ho Nucl. Data Tables A 5 1-242
10. Hale G and Young P 1989 pjef22/B-10:1 5-B-10 LANL EVAL-MAR89
11. Hatanaka H, Sano K and Yasukocki H 1992 Clinical results of boron neutron capture therapy Progress in Neutron Capture Therapy for Cancer (New York: Plenum) pp 561-8
12. Ichikawa H and Fukumori Y 2002 Formulation considerations of gadolinium lipid-nanoemulsion for intraveneous delivery to tumor in neutron capture therapy Research and Development in Neutron Capture Therapy: Proc. 10th Int. Congress on Neutron Capture Therapy pp 797-801
13. Joel D et al 1997 Uptake of BPA into glioblastoma multiforme correlates with tumor cellularity Advances in Neutron Capture Therapy pp 225-8
14. Joensuu H et al 2002 Preliminary results of the first Finnish BPA-based BNCT trial on preliminary glioblastoma Research and Development in Neutron Capture Therapy: Proc. 10th Int. Congress on Neutron Capture Therapy pp 1093-6
15. Johns H and Cunningham J 1983 The Physics of Radiology (Charles C Thomas Publishing)
16. Kagehira K, Sakurai Y, Kobayashi T, Kanda K and Akine Y 1994 Physical dose evaluation on gadolinium neutron capture therapy Annu. Rep. Res. React. Inst. Kyoto Univ. 27 42-56
17. Maeda T, Sakurai Y, Kobayashi T, Kanda K and Akine Y 1995 Calculation of the electron energy spectrum for gadolinium capture therapy Annu. Rep. Res. React. Inst. Kyoto Univ. 28 39-43
18. Masiaskowski J, Horton J and Peters L 1992 Gadolinium neutron capture therapy for brain tumors: a computer study Med. Phys. 19 1277-84
19. Masunaga, S, Ono K, Suzuki M, Sakurai Y, Takagaki M, Kobayashhi T, Kinashi Y and Akaboshi M 1999 Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction J. Cancer Res Clin. Oncol. 125 609-14
20. Menapace E et al 1982 pjef-22/Gd-157:1 64-GD-157 NEA RCOM-JUN82
21. Miller G, Hertel N, Wehring B and Horton J 1993 Gadolinium neutron capture therapy Nucl. Technol. 103 320-30
22. Miloshevsky G, Tolach V I, Shani G and Rozin S 2002 Calculated gadolinium atomic electron energy levels and Auger electron emission probability as a function of atomic number Z Nucl. Instrum. Methods Phys. Res. B 192 360-4
23. Nguyen T, Brownell G, Holden S, Kahl S, Miura M and Teicher B 1993 Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations Radiat. Res. 133 33-40
24. Ono K, Masunaga S I, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T and Akuta K 1996 Radiobiological evidence suggesting hetergeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy Int. J. Radiat. Oncol. Biol. Phys. 34 1083-6
25. Ono K, Masunaga S I, Suzuki M, Kinashi Y, Takagaki M and Akabosahi M 1999 The combined effect of boronophenylalanine and borocapate in boron neutron capture therapy for SCVII tumors in mice Int. J. Radiat. Oncol. Biol. Phys: 43 431-6
26. 103Pd source Appl. Radiat. Isot. 55 775-82
27. Stasio G et al 2002 New criteria for GdNCT agents Research and Development in Neutron Capture Therapy: Proc. 10th Int. Congress on Neutron Capture Therapy pp 813-17
28. Stragliotto G and Fankhauser H 1995 Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors Neurosurgery 36 285-92
29. Tokuyye K, Tokita N, Akine Y, Nakayama H, Sakurai Y, Kobayashi T and Kanda K 2000 Comparison of radiation effects of gadolinium and boron neutron capture reactions Strahlenther. Onkol. 176 81-3
30. 60Co hot particle depth-dose distributions and Monte Carlo calculations Radiat. Prot. Dosim. 85 507-11
31. Wallace S, Mathur J and Allen B 1994 Treatment planning figures of merit in thermal and epithermal boron neutron capture therapy of brain tumors Phys. Med. Biol. 39 897-906
32. Watanabe T, Ichikawa H and Fukumori Y 2002 Tumor accumulation of gadolinium in lipid-nanoparticles intraveneously injected for neutron capture therapy of cancer Eur. J. Pharm. Biopharm. 54 119-24
33. Wheeler F, Nigg D, Capala J, Watkins P, Vroegindeweij C, Auterinen I, Seppala T and Bluel D 1999 Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics Med. Phys. 26 1237-44
34. 192Ir brachytherapy sources Int. J. Radiat. Oncol. Biol. Phys. 36 689-97
35. Yang W, Barth R, Rotaru J, Boesel C, Wilke D, Bresnahan J, Hadjiconstantinou M, Goettl V, Joel D and Nawrocky M 2000 Boron neutron capture therapy of brain tumors: functional and neutropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine J. Neuro-Oncol. 48 179-90
36. Zhang T, Matsumura A, Yamamoto T, Yoshida F, Sakurai Y, Kobayashi T, Ono K and Nose T 2002 A comparison of in vivo Gd-NCT trial by using two targeting compounds: Gd-BOPTA and Gd-DTPA Research and Development in Neutron Capture Therapy: Proc. 10th Int. Congress on Neutron Capture Therapy pp 807-12